Aller au contenu

Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial

Nom du journal : ESMO Open

Année : 2021

Volume : 7

Page de départ : 100340

Auteurs: Moshyk A, Kurt M, Sofeu CL, Gaudin AF, Branchoux S, Bellera C, Rondeau V, Italiano A,